NCBI PubMed Central
open access
Most-Favored-Nation Benchmarking Versus Value-Based Contracting: Institutional Fit of Pharmaceutical Pricing Tools in the United States, Canada, and the United Kingdom.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pricing and Reimbursement in U.S. Pharmaceutical Markets#485686
- Optimizing Operations of a Pharmaceutical Regional Distribution Hub under Varying Regulatory Environments#644976
- Analysis of the impact of national centralized volume-based procurement drug policy on the market dynamics of tuberculosis drugs.#236360
- In Pursuit of Profitability and Effectiveness in the Global Pharmaceutical Industry: Comments on Professor Walker's Four Challenges#493931
- Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts#163637
Record · ID 214049
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive